MSON
Misonix, Inc.
NasdaqGM
People also watch:MOCOIRIXMLABMTSCKEQU
6.08-0.12 (-1.94%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close6.20
Open6.06
Bid6.09 x 400
Ask6.17 x 500
52wk Range3.83 - 12.00
Day's Range6.05 - 6.20
Volume1,044
Avg Vol (3m)12,014
As of 4:00 PM EDT. Market closed.
  • Misonix, Inc.: Gathering momentum, can it sustain its performance?
    Capital Cube9 days ago

    Misonix, Inc.: Gathering momentum, can it sustain its performance?

    Misonix, Inc. relative valuation is UNDERVALUED and it has a fundamental analysis score of 72.Our analysis is based on comparing Misonix, Inc. with the following peers – Stryker Corporation, Bovie Medical Corporation, Integra LifeSciences Holdings Corporation, Cesca Therapeutics Inc., Intuitive Surgical, Inc., Johnson & Johnson, Cynosure, Inc. Class A, Biostage, Inc., Medtronic Plc and Allied […] (Read more...) The post Misonix, Inc.: Gathering momentum, can it sustain its performance? appeared first on CapitalCube.

  • Misonix, Inc. :MSON-US: Earnings Analysis: Q3, 2016 By the Numbers
    Capital Cube2 months ago

    Misonix, Inc. :MSON-US: Earnings Analysis: Q3, 2016 By the Numbers

    Click here to see latest analysisMisonix, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Misonix, Inc. – Stryker Corporation, Integra LifeSciences Holdings Corporation, Intuitive Surgical, Inc., Cynosure, Inc. Class A and Johnson & Johnson (SYK-US, IART-US, ISRG-US, CYNO-US and JNJ-US) that have also […] (Read more...) The post Misonix, Inc. :MSON-US: Earnings Analysis: Q3, 2016 By the Numbers appeared first on CapitalCube.